Australia's Noxopharm rises on autoimmune drug trial initiation

Noxopharm

16/07/2025 04:44

** Shares of Noxopharm NOX.AX rise nearly 46% to A$0.07, their biggest pct gain since October 4, 2023

** Stock hits highest level since June 6

** Biotech co says first dose of SOF-SKN, a drug candidate for autoimmune diseases was administered to trial participant

** Around 422,086 shares traded, 2.2x the 30-day avg

** YTD, shares down 24.7%, including today's move

 (Reporting by Ananya Verma in Bengaluru)

 ((Ananya.Verma@thomsonreuters.com;))